Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

33
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
33
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

22
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
22
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

16
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
16
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

40
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
40
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

48
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
48
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

32
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
32

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Single center automated, multi-source deeply phenotyped heart transplant registry as a template to build tailored data infrastructure.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026
Same author

Recovery From Heart Failure: Microvascular Mechanisms.

Circulation·2026
Same author

Impact of cannabidiol on myocardial recovery in patients with acute myocarditis: primary results of the ARCHER study.

ESC heart failure·2026
Same author

Hypatia: Comparative Isoform Profiling Across Cell Populations from Long-Read Single-Cell Transcriptomes.

bioRxiv : the preprint server for biology·2026
Same author

The environmental exposome in heart failure risk and progression.

Nature reviews. Cardiology·2026
Same author

Mechanically Reducing Cardiac Preload With the preCARDIA System in Acutely Decompensated Heart Failure.

JACC. Heart failure·2025

Related Experiment Video

Updated: Sep 11, 2025

Myocardial Infarction and Functional Outcome Assessment in Pigs
12:03

Myocardial Infarction and Functional Outcome Assessment in Pigs

Published on: April 25, 2014

28.1K

Apparent End-Stage Heart Failure Forced Toward a Successful Myocardial Recovery.

Basha Behrman1, Arvind Bhimaraj2

  • 1Department of Cardiology, DeBakey Heart and Vascular Institute, Houston Methodist Hospital, Houston, Texas, USA.

JACC. Case Reports
|August 15, 2025
PubMed
Summary

Native heart recovery is possible in cardiogenic shock (CS) patients requiring temporary mechanical circulatory support (t-MCS). This case highlights individualized, prolonged medical therapy as a viable alternative to heart replacement therapy.

Keywords:
acute heart failurecardiomyopathyinotropes

More Related Videos

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

8.6K
Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
09:12

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery

Published on: March 27, 2018

9.5K

Related Experiment Videos

Last Updated: Sep 11, 2025

Myocardial Infarction and Functional Outcome Assessment in Pigs
12:03

Myocardial Infarction and Functional Outcome Assessment in Pigs

Published on: April 25, 2014

28.1K
Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

8.6K
Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
09:12

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery

Published on: March 27, 2018

9.5K

Area of Science:

  • Cardiology
  • Critical Care Medicine
  • Regenerative Medicine

Background:

  • Strategies for promoting myocardial recovery in cardiogenic shock (CS) are not well-established.
  • CS often necessitates advanced interventions, including temporary mechanical circulatory support (t-MCS).

Observation:

  • A 51-year-old female with severe heart failure (LVEF <10%) presented with CS, requiring milrinone and t-MCS.
  • Diagnostic workup revealed no clear etiology, but PET-FDG imaging showed colonic uptake, leading to biopsy-confirmed tubulovillous adenoma with high-grade dysplasia.
  • Colectomy and colostomy were performed; malignancy was excluded, but heart replacement therapy was contraindicated due to the colostomy.

Findings:

  • The patient underwent prolonged guideline-directed medical therapy (GDMT) with inotropic support.
  • t-MCS was successfully weaned, and inotropes were discontinued after several months.
  • The patient achieved significant native heart recovery (LVEF 35-39%) and remains ambulatory.

Implications:

  • This case demonstrates "forced recovery" through extended GDMT in a CS patient with contraindications to heart replacement therapy.
  • Native heart recovery is achievable even in severe CS cases requiring t-MCS, underscoring the importance of personalized treatment strategies.
  • Further research is warranted to identify predictors of recovery and develop targeted approaches for native heart recovery.